Results 31 to 40 of about 4,697,552 (378)

The Clinical Efficaciency and the Cost-Effectiveness of Reperfusion Therapy in Myocardial Infarction

open access: yesАрхивъ внутренней медицины, 2015
The goal of the research was to value the cost-effectiveness and the efficacy of reperfusion therapy in myocardial infarction including one — year prospective examenation.Methods.
A. M. Nazarov, R. I. Saifutdinov
doaj   +1 more source

Referring STEMI Patient: When and Where?

open access: yesMajalah Kardiologi Indonesia, 2013
Management of STEMI patients consist of initial recognition and diagnosis, early routine medication, and reperfusion therapy. Primary PCI has been set as default strategy for STEMI reperfusion in PCI-capable hospital.
Kurniawan Agung Yuwono
doaj   +1 more source

Impact of ECG findings and process-of-care characteristics on the likelihood of not receiving reperfusion therapy in patients with ST-elevation myocardial infarction: results of a field evaluation. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: Many patients with ST-elevation myocardial infarction (STEMI) do not receive reperfusion therapy and are known to have poorer outcomes.
Kevin A Brown   +11 more
doaj   +1 more source

Association between time to reperfusion and outcome is primarily driven by the time from imaging to reperfusion [PDF]

open access: yes, 2016
Background and Purpose A progressive decline in the odds of favorable outcome as time to reperfusion increases is well known. However, the impact of specific workflow intervals is not clear.; Methods We studied the mechanical thrombectomy group (n=103 ...
Cerda, Neus   +8 more
core   +2 more sources

Mismatch-based delayed thrombolysis: a meta-analysis [PDF]

open access: yes, 2010
<p><b>Background and Purpose</b>: Clinical benefit from thrombolysis is reduced as stroke onset to treatment time increases. The use of "mismatch" imaging to identify patients for delayed treatment has face validity and has been used in
Anthony J. Furlan   +6 more
core   +1 more source

Imaging Acute Stroke: From One-Size-Fit-All to Biomarkers

open access: yesFrontiers in Neurology, 2021
In acute stroke management, time window has been rigidly used as a guide for decades and the reperfusion treatment is only available in the first few limited hours.
Jianfei Lu   +8 more
doaj   +1 more source

The future of ischemic stroke: flow from prehospital neuroprotection to definitive reperfusion. [PDF]

open access: yes, 2014
Recent advances in ischemic stroke enable a seamless transition of the patient flow from the prehospital setting to definitive reperfusion, without the arbitrary separation of therapeutic phases of ischemia based on time alone.
Ip, Hing Lung, Liebeskind, David S
core   +1 more source

Using ESN-Smartphone Application to Maximize AIS Reperfusion Therapy in Alexandria Stroke Network: A Stroke Chain of Survival Organizational Model

open access: yesFrontiers in Neurology, 2021
Background: In developing countries like Egypt, the clinical workflow of stroke management is poorly established due to the lack of awareness of the stroke patients concerning their need of therapeutic intervention and the poor identification of ...
Ossama Yassin Mansour   +33 more
doaj   +1 more source

Disentangling Sex Differences in Use of Reperfusion Therapy in Patients With Acute Ischemic Stroke

open access: yesStroke, 2020
Supplemental Digital Content is available in the text. Background and Purpose: Previous studies from local settings have reported that women with acute ischemic stroke have a lower chance of receiving reperfusion therapy treatment, including intravenous ...
Jeppe Mainz   +4 more
semanticscholar   +1 more source

Clinically Ineffective Reperfusion After Endovascular Therapy in Acute Ischemic Stroke

open access: yesStroke, 2022
Endovascular treatment is a highly effective therapy for acute ischemic stroke due to large vessel occlusion. However, in clinical practice, nearly half of the patients do not have favorable outcomes despite successful recanalization of the occluded ...
X. Nie   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy